440 related articles for article (PubMed ID: 32560668)
1. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
2. Deposition of Phosphorylated α-Synuclein and Activation of GSK-3β and PP2A in the PS19 Mouse Model of Tauopathy.
Takaichi Y; Chambers JK; Ano Y; Takashima A; Nakayama H; Uchida K
J Neuropathol Exp Neurol; 2021 Sep; 80(8):731-740. PubMed ID: 34151989
[TBL] [Abstract][Full Text] [Related]
3. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy.
Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H
J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic aggregation of TDP43 and topographic correlation with tau and α-synuclein accumulation in the rTg4510 mouse model of tauopathy.
Nakayama Y; Chambers JK; Takaichi Y; Uchida K
J Neuropathol Exp Neurol; 2024 Jun; ():. PubMed ID: 38879441
[TBL] [Abstract][Full Text] [Related]
5. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β.
Kawakami F; Suzuki M; Shimada N; Kagiya G; Ohta E; Tamura K; Maruyama H; Ichikawa T
FEBS J; 2011 Dec; 278(24):4895-904. PubMed ID: 21985244
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
Duka T; Duka V; Joyce JN; Sidhu A
FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
[TBL] [Abstract][Full Text] [Related]
10. Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice.
Yanagisawa D; Hamezah HS; Pahrudin Arrozi A; Tooyama I
Sci Rep; 2021 May; 11(1):9623. PubMed ID: 33953293
[TBL] [Abstract][Full Text] [Related]
11. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
[TBL] [Abstract][Full Text] [Related]
12. Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer's Disease.
Bihaqi SW; Alansi B; Masoud AM; Mushtaq F; Subaiea GM; Zawia NH
Curr Alzheimer Res; 2018; 15(12):1114-1122. PubMed ID: 30068273
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain.
Sahara N; DeTure M; Ren Y; Ebrahim AS; Kang D; Knight J; Volbracht C; Pedersen JT; Dickson DW; Yen SH; Lewis J
J Alzheimers Dis; 2013; 33(1):249-63. PubMed ID: 22941973
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
[TBL] [Abstract][Full Text] [Related]
15. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
Ren Y; Lin WL; Sanchez L; Ceballos C; Polydoro M; Spires-Jones TL; Hyman BT; Dickson DW; Sahara N
J Alzheimers Dis; 2014; 38(3):589-600. PubMed ID: 24028867
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein aggregates are phosphatase resistant.
Choi SG; Tittle T; Garcia-Prada D; Kordower JH; Melki R; Killinger BA
Acta Neuropathol Commun; 2024 May; 12(1):84. PubMed ID: 38822421
[TBL] [Abstract][Full Text] [Related]
17. Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage.
Mehta SL; Kim T; Chelluboina B; Vemuganti R
Neuromolecular Med; 2023 Mar; 25(1):94-101. PubMed ID: 36447045
[TBL] [Abstract][Full Text] [Related]
18. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
19. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
[TBL] [Abstract][Full Text] [Related]
20. Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells.
Gąssowska M; Czapski GA; Pająk B; Cieślik M; Lenkiewicz AM; Adamczyk A
PLoS One; 2014; 9(4):e94259. PubMed ID: 24722055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
